Literature DB >> 10704747

Neuroprotective effects of chronic estradiol benzoate treatment on hippocampal cell loss induced by status epilepticus in the female rat.

S Reibel1, V André, S Chassagnon, G André, C Marescaux, A Nehlig, A Depaulis.   

Abstract

Neuroprotective properties of estrogen are supported by extensive experimental evidence. In this study, the effects of estrogen were examined on the neurodegeneration secondary to status epilepticus induced by kainic acid in the rat. Chronic supplementation of ovariectomized rats with estradiol benzoate (20 microg/day) did not modify the expression of seizures monitored by electroencephalography, but significantly reduced cellular loss in the hippocampus. This neuroprotection was in particular observed in the dentate hilus and CA3 pyramidal layer when treatment with estradiol benzoate was started five days before status epilepticus induction. These findings suggest that estrogen can exert neuroprotective effects in a model of status epilepticus, in the absence of anti-epileptic properties.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704747     DOI: 10.1016/s0304-3940(00)00784-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  20 in total

Review 1.  Sex and hormonal influences on seizures and epilepsy.

Authors:  Jana Velíšková; Kara A Desantis
Journal:  Horm Behav       Date:  2012-04-04       Impact factor: 3.587

Review 2.  The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Epilepsia       Date:  2006-09       Impact factor: 5.864

3.  Gonadal status-dependent effects of in vivo β-estradiol administration to female rats on in vitro epileptiform activity induced by low [Mg2+]₀ in combined hippocampus-entorhinal cortex slices.

Authors:  Jana Velíšková; Libor Velíšek
Journal:  Epilepsy Res       Date:  2013-09-20       Impact factor: 3.045

4.  Seizure susceptibility in intact and ovariectomized female rats treated with the convulsant pilocarpine.

Authors:  Helen E Scharfman; Jeffrey H Goodman; Marie-Aude Rigoulot; Russell E Berger; Susan G Walling; Thomas C Mercurio; Kerry Stormes; Neil J Maclusky
Journal:  Exp Neurol       Date:  2005-08-09       Impact factor: 5.330

Review 5.  Neuroendocrine considerations in the treatment of men and women with epilepsy.

Authors:  Cynthia L Harden; Page B Pennell
Journal:  Lancet Neurol       Date:  2013-01       Impact factor: 44.182

6.  Neuroprotection against excitotoxic brain injury in mice after ovarian steroid depletion.

Authors:  P Elyse Schauwecker; Ruth I Wood; Ariana Lorenzana
Journal:  Brain Res       Date:  2009-02-21       Impact factor: 3.252

Review 7.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

Review 8.  The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy.

Authors:  Doodipala Samba Reddy
Journal:  Epilepsy Res       Date:  2009-04-29       Impact factor: 3.045

Review 9.  Neuroprotective actions of brain aromatase.

Authors:  Colin J Saldanha; Kelli A Duncan; Bradley J Walters
Journal:  Front Neuroendocrinol       Date:  2009-05-18       Impact factor: 8.606

10.  Rescue from Sexually Dimorphic Neuronal Cell Death by Estradiol and PI3 Kinase Activity.

Authors:  Hui-Yun Cheng; Shin-Hui Hung; Po-Ju Chu
Journal:  Cell Mol Neurobiol       Date:  2015-09-14       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.